Sycomore Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Hold
23,318
1.12% 26
2026
Q1
$14.4M Hold
23,318
2.01% 17
2025
Q4
$14.4M Hold
23,318
2.39% 14
2025
Q3
$14.4M Hold
23,318
2.4% 15
2025
Q2
$14.4M Hold
23,318
2.24% 15
2025
Q1
$14.4M Hold
23,318
2.05% 16
2024
Q4
$14.4M Buy
23,318
+7,929
+52% +$4.36M 2.06% 16
2024
Q3
$9.53M Buy
15,389
+6,426
+72% +$3.8M 1.58% 21
2024
Q2
$5M Buy
8,963
+781
+10% +$447K 0.88% 34
2024
Q1
$4.89M Buy
8,182
+1,275
+18% +$715K 1.07% 29
2023
Q4
$3.67M Sell
6,907
-2,437
-26% -$1.18M 0.79% 38
2023
Q3
$4.7M Buy
9,344
+2,003
+27% +$1.07M 1.2% 30
2023
Q2
$3.75M Buy
7,341
+4,275
+139% +$2.31M 0.88% 35
2023
Q1
$1.72M Sell
3,066
-1,869
-38% -$1.05M 0.49% 40
2022
Q4
$2.67M Sell
4,935
-8,468
-63% -$4.49M 0.74% 42
2022
Q3
$6.89M Buy
13,403
+1,852
+16% +$1.04M 1.95% 13
2022
Q2
$6.19M Sell
11,551
-6,806
-37% -$3.75M 1.45% 15
2022
Q1
$10.9M Buy
18,357
+400
+2% +$230K 1.9% 13
2021
Q4
$11.9M Sell
17,957
-2,810
-14% -$1.75M 1.83% 14
2021
Q3
$12M Sell
20,767
-664
-3% -$364K 1.75% 13
2021
Q2
$10.6M Buy
21,431
+1,765
+9% +$833K 1.46% 18
2021
Q1
$9.02M Sell
19,666
-7,328
-27% -$3.5M 1.75% 21
2020
Q4
$12.6M Buy
26,994
+5,661
+27% +$2.65M 2.63% 11
2020
Q3
$9.45M Buy
21,333
+2,689
+14% +$1.11M 2.75% 10
2020
Q2
$6.54M Sell
18,644
-5,167
-22% -$1.73M 2.92% 12
2020
Q1
$6.75M Sell
23,811
-12,724
-35% -$4.01M 3.23% 9
2019
Q4
$11.9M Buy
36,535
+4,916
+16% +$1.49M 5.66% 6
2019
Q3
$8.97M Buy
31,619
+9,608
+44% +$2.75M 4.76% 5
2019
Q2
$6.42M Buy
+22,011
New +$6.06M 3.73% 10

Other funds holding TMO

Sycomore Asset Management's TMO Position: Q2 2026 in Review

Sycomore Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 23,318 shares worth $10.5M. The position accounts for 1.12% of the portfolio, ranked #26.

Sycomore Asset Management first reported a position in TMO in Q2 2019 and has held it in 29 quarters since. The position peaked at $14.4M in Q1 2026. 954 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sycomore Asset Management held 23,318 shares of Thermo Fisher Scientific worth $10.5M as of Q2 2026.
  • Sycomore Asset Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 1.12% of Sycomore Asset Management's portfolio in Q2 2026, its #26 holding.
  • Sycomore Asset Management first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 29 quarters since.
  • Sycomore Asset Management's Thermo Fisher Scientific position peaked at $14.4M in Q1 2026.
  • 954 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sycomore Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.